Beacon Pharmaceuticals – Oncology Expert from Bangladesh
Beacon Pharmaceuticals
Beacon Pharmaceuticals PLC is a Bangladeshi pharmaceutical company that began operations in 2006. Its head office is in Dhaka and its plant is in Bhaluka, Mymensingh. It became a public limited company in 2008, and its shares were listed on the Dhaka Stock Exchange in 2010. The plant occupies a site of about 30 acres (around 12 hectares).
Oncology is Beacon's main focus. In 2009 it became the first company in Bangladesh to make cancer medicines, and in 2012 the first in the country to export them, with the first shipment going to Uzbekistan. Cancer drugs are made in a dedicated unit equipped with isolators.
Besides oncology, Beacon makes antibiotics, cardiovascular and gastrointestinal medicines, anticoagulants and painkillers. Its cephalosporin antibiotic unit holds EU GMP certification.
Unifarm carries Beacon's medicines for EGFR-mutated non-small cell lung cancer: Ositag and Tagrix 80 (both osimertinib).